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Abstract. In the health capital model, the main function of health services is not to 
produce health, but to support the person in their self-production investments. In the 
health context there are three types of decision support tools, depending on the role 
of the provider (e.g. clinician) and person. Non-mediative tools are designed to help 
the clinician decide what is best for the patient. Intermediative Patient Decision Aids 
are designed to help the clinician and patient decide together, in an encounter, what 
is best for the patient. Apomediative Personalised Decision Support Tools are 
designed to help the person decide what is best for themselves, including whether 
to seek a professional consultation and/or to prepare for, and engage in, an 
intermediative consultation. Only preference-sensitive apomediative support tools 
ensure that the key requirements of self-produced health are met, along with legally 
informed and preference-based consent to any subsequent provider action. The 
desirable form of apomediative support is a publicly accessible, direct-to-citizen, 
provider-independent, multi-criteria analysis-based decision support of the sort 
available in many other areas of self-production. Which (UK), Tænk (Denmark), 
Choice (Australia) and numerous other comparison magazines and websites provide 
independent multi-criterial support for decisions on, for example, which food and 
transport to buy to self-produce nutrition and movement. A personalised decision 
support tool for the statin decision is provided as illustration: Should I go to my 
general practitioner and ask for a statin prescription or go to discuss taking statins, 
in the light of the preliminary opinion of the tool?  
Keywords. apomediative, inter-mediative, self-produced health, health capital, 
decision support tool, multi-criteria decision analysis 
1. Background: the Health Capital paradigm 
In the health capital paradigm [1–5], an individual person has, at any point of time, a 
stock of health capital. It is valued in terms of its future returns, both as a source of utility 
in itself and its yields in areas of life beyond health (work, leisure, etc.) for the person 
and their significant others. The person’s initial stock of health capital is inherited at 
conception. Their health asset stock depreciates through life as a result of biological 
aging, but, if in any period during life, the amount of health-enhancing investment 
exceeds the amount of health-depletion by more than the amount of depreciation, the 
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stock of health capital will have grown. If vice versa, the stock will have fallen. To the 
extent they are in control of their actions and have the relevant resources, including 
financial ones, to implement their choices – an extent which varies from place to place 
and individual to individual - the person’s health capital is self-produced. In this 
production role they spend time, effort, and money acquiring inputs that enhance or 
deplete their health through consumption of goods and services.  
Among these consumed inputs are health and medical goods and services. The 
person’s demand for health services is therefore derived from their demand for health. 
In the health capital paradigm, the function of health services (as of food and transport 
services) is not to produce health, but to support the person in their self-production of 
health (as of meals and movement). Health professionals, such as GPs, can provide 
decision support to the individual in deciding how to enhance their health stock, or adapt 
to its depreciation. In many situations, such as hospitals, they can also supply the goods 
and services (tests and treatments) necessary to implement the decisions, in the same 
way as the supermarket supplies the food necessary to implement meal decisions, and 
the transport system supplies the vehicles necessary to implement movement decisions. 
Given the challenging task of obtaining and integrating personalised information 
and preferences, decision support is essential for the informed and preference-based 
decision making that is key to optimising self-produced health. 
2. Types of Decision Support Tool for self-produced health  
In the health context we can distinguish main three types of Decision Support Tool 
(DST), depending on the role of the provider (here, clinician) and person [6]. 
Non-mediative Clinician Decision Support Tools (often misleadingly called Clinical 
Decision Support Tools) are designed to help the clinician decide what is best for the 
patient. Clinician’s resistance to even such non-mediative DSTs has been documented 
by Liberati et al., along with the nature and sources of the resistance [7]. 
Intermediative Decision Support Tools (often called Shared Decision Making 
Support Tools or Patient Decision Aids) are designed to help the clinician and patient 
decide together what is best for the patient. The options included in the aid are often 
restricted or ‘censored’ to those which the clinician feels relevant to the patient. The 
attempts by Elwyn and others to introduce intermediative decision aids into practice, 
such as Option Grids or Mayo Cards, have also failed to overcome the resistance of many 
clinicians, extending to not using the aid despite having agreed to do so, or not delivering 
it in the intended way [8-11].  
Apomediative Decision Support Tools are a ‘direct-to-citizen’ resource designed to 
help the person decide what is best for themselves, including whether to seek a health 
service consultation and/or to prepare for, and engage in, an intermediative consultation. 
Insofar as they contain an uncensored set of options and commit to the personalised 
assessment of benefits and harms of all these, apomediative support tools help ensure 
that the key requirements of self-produced health are met, along with legally informed 
and preference-based consent to any subsequent provider action. The clinician will often 
become involved in the making of the supported decision subsequently – 
intermediatively - not only because they have greater relevant knowledge (e.g. ability to 
identify contraindications), but also because only they have the power to order a test, 
prescribe a medication, or refer for, or undertake, surgery.  
The person can agree to a switch of a previously-completed apomediative DST into 
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a clinician-managed intermediative tool, but this does not change its fundamental nature 
and intention, which is totally different from that of a pure intermediative one [6].  
Full implementation of the person-centred paradigm, as captured in the Digital 
Health Manifesto [12], requires ‘dually-personalised’ decision support tools. In these the 
person’s personal preferences (criterion weightings) are combined with the most 
personalised estimates available for the performance of all options on the criteria 
important to the person. ‘Single personalisation’, involving only the latter, does not 
respect the preference-sensitivity of the decision. 
3. Apomediative decision support for self-produced health 
Apomediation can take multiple forms, including ‘Dr Google’, social media networks, 
patient groups and librarians, so the quality of apomediative support can vary 
enormously. In order to ensure its analytical and empirical credibility, one key criterion 
is independence from providers with their own conflicts of interest, whether financial, 
organisational or professional. 
The desired form of apomediative support is of the sort available in other areas of 
self-production. Which (UK), Tænk (Denmark), Choice (Australia) and many other 
comparison magazines and websites provide classic examples of DSTs that support the 
decision as to which washing machine, which holiday package, or which bicycle to buy 
in carrying out self-produced home maintenance, self-produced leisure, and self- 
produced transportation. These DSTs could become more personalised by providing 
interactive weighting of the multiple criteria on which the products are rated, but the 
majority have pre-entered criteria weights, so as to be able to identify a ‘Best Buy’ or 
‘Best Value’ for the whole readership. Personalised Decision Support Tools (PDSTs) 
also differ in having the person provide the ratings for those criteria where they are the 
expert, e.g. treatment burden and burden of out-of-pockets costs.  
To permit analytically-credible, dually-personalised, home-based support at or near 
the point of decision, PDSTs should take the form of computerised, online 
implementations of Multi-Criteria Decision Analysis (MCDA), a technique which uses 
the accessible structure and ‘language’ of comparison websites.  
The PDSTs in health must, like the above examples, be publicly accessible – not 
available only through a health professional or provider – even if they are not free.  
In self-produced health such PDSTs will contribute significantly to the ability of the 
person to consent to actions (testing, treatment, etc.) following from a decision taken 
with a health provider – as well as help them decide whether to engage with a health 
provider in the first place. We argue that only final decision deliberation preceded by a 
formal MCDA-based PDST (at home or in the clinic) can meet the ethical requirements 
of person-centred care. Furthermore, the PDST embodies the transparency and 
explicitness necessary for the legally-required informed and preference-based consent to 
any subsequent action in which a health provider is involved. 
Concerns about the ability of persons to engage with, and properly interpret the 
output from a PDST, must be addressed in the tool, but informed consent to engaging 
with it is required on opening. A disclaimer makes clear that apomediators do not have 
the ‘duty of care’ to persons that health professionals have to patients. On the other hand, 
they must respect all the rights of consumers to accurate and unbiased information and 
transparency in any processing of it. 
The PDST produces an opinion not a recommendation – an opinion which is 
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normally preliminary to a ‘deliberative’ phase that ends with a decision. This phase may 
vary from a few seconds cogitation by the person by themselves (e.g. ‘I will go with the 
winning option’) to extensive consultations with other sources, including, in a switch to 
intermediation, with health professionals who may be able to draw on more sophisticated 
biomarkers. The decision taken at the end of the deliberation phase may or may not be 
in line with the preliminary opinion. Concordance, or lack of it, between the preliminary 
opinion and the final decision cannot be regarded as an indicator of its value. 
4. Self-sourced inputs into apomediative decision support tools 
It is in the nature of the more involving forms of apomediative decision support that 
many inputs are self-sourced. Tools developed in the MCDA technique usually require 
four broad types of self-sourcing. 1. Completion of an online instrument. 2. Obtaining 
output from a personal device, home kit, wearable and/or, where possible, the person’s 
electronic health record. 3. Rating how well all options perform on those criteria where 
the person is the expert. 4. Assigning relative importance weights to the criteria.  
The illustration provided here is a dually-personalised decision support tool for the 
statin decision: Should I go to my general practitioner and ask for a statin prescription, 
or make an appointment to discuss statins in the light of the tool’s preliminary opinion?   
The tool involves the person completing an online instrument to obtain estimates of 
their personalised risks of All-Cause Mortality and Cardio-vascular Mortality in the next 
ten years; self-assessing their blood pressure and total cholesterol level, which are the 
inputs required, along with age, sex and smoking status, to complete the EuroSCORE-
based instrument; self-rating the treatment burden of statins; and assigning  importance 
weights to four criteria (10 year mortalities, statin side effects and statin burden). 
The tool is derived directly from the study of Støvring et al. 2013 [13] and simply 
translates the data in that study into decision support format and adds two of the criteria 
that are needed in a PDST. To engage with the tool, go to https://goo.gl/H7P51r. 
Simpler forms of apomediative decision support tool require less involvement. In 
the modification of the statin selection aid of Naci et al. to make it preference-sensitive 
and yield personalised option scores (https://goo.gl/oVPpab) the person need only supply 
their criterion weights. In the translation of the MAGIC decision aid on aspirin as 
primary prevention to achieve the same objective (https://goo.gl/5MdWFA), the person 
supplies their criterion weights and ratings for the ‘practical consequences’. 
5. Conclusion 
To the extent that personalised health is self-produced health, high quality apomediative 
decision support tools are required. Such tools will be able to draw on the outputs of a 
rapidly increasing number and range of home tests, wearable devices, health records and 
internet resources. Online assessment and evaluative instruments should be developed 
and/or modified to facilitate the apomediative approach, as well as to develop health 
service providers’ competencies in using these tools in subsequent intermediation. 
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